Selective Personalized Radioimmunotherapy for Locally Advanced Non-Small-Cell Lung Cancer Trial.

Nitin Ohri Shruti JollyBenjamin T CooperRafi KabarritiWilliam R BodnerJonathan KleinChandan GuhaViswanathan Shankar Elaine Shum Joshua K Sabari Haiying ChengRasim A GucalpEnrico CastellucciAngel Qin Shirish M Gadgeel Balazs Halmos

Published in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)

Pembrolizumab and risk-adapted radiotherapy, without chemotherapy, are a promising treatment approach for patients with LA-NSCLC with a PD-L1 TPS of ≥50%.

Keyphrases

advanced non small cell lung cancer
epidermal growth factor receptor
locally advanced
early stage
clinical trial
radiation therapy
study protocol
radiation induced
phase iii
tyrosine kinase
randomized controlled trial
phase ii
chemotherapy induced
replacement therapy